Renal Biomarkers: Technologies and Global Markets

Renal Biomarkers: Technologies and Global Markets

Report Scope:

This report incorporates an in-depth analysis of the renal biomarker market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the CAGR for renal biomarkers.

The scope of the report extends only to renal biomarker consumables and not devices used to study renal biomarkers. All types of renal biomarkers have been considered in research, clinical trials and for diagnostic purposes.

This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW) region. For market estimates, data is provided for 2021 as the base year, 2022 and forecast through year-end 2027.

Report Includes:

41 data tables and 24 additional tables

A detailed overview and up-to-date analysis of the global markets for renal biomarkers

Analyses of the global market trends, with market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Estimation of the actual market size and revenue forecast for renal biomarkers market, and corresponding market share analysis by assay type, application, end user, and region

Updated information on market drivers and opportunities for renal biomarkers, key shifts, regulations and industry specific challenges, and other demographic factors that will shape the market demand over the coming years (2022-2027)

Identification of the companies best positioned to meet the demand owing to their proprietary technologies, product launches, mergers and acquisitions, and other market strategic advantages

Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues

Patent activity and review of patent grants for biomarkers and related technologies

Descriptive company profiles of the market leading players, including BioMerieux, Gentian Diagnostic, Proteomics International, Thermo Fisher Scientific, SphingoTec, and BioPorto

Companies Mentioned<\b>

ABBOTT LABORATORIES
BECKMAN COULTER INC.
Bio-Rad
BIOMERIEUX
Bioporto A/s
ENZO BIOCHEM INC.
Gentian Diagnostic Ab
HYTEST LTD.
Nephrosant
Nexelis
Proteomics International Laboratories Ltd.
RANDOX LABORATORIES LTD.
ROCHE (F. HOFFMANN-LA ROCHE AG)
Sphingotec
THERMO FISHER SCIENTIFIC